From January 1, 2022 to March 31, 2022, the company has repurchased 1,940,000 shares, representing 2.29% for $125 million. With this, the company has completed the repurchase of 1,940,000 shares, representing 2.29% for $125 million under the buyback announced on December 10, 2020.
Integra LifeSciences Holdings Corporation
Equities
IART
US4579852082
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.24 USD | +3.18% | +0.90% | -32.86% |
04/04 | North American Morning Briefing : Focus Turns to -2- | DJ |
03/04 | Citigroup Upgrades Integra LifeSciences to Neutral From Sell With $38 Price Target | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.86% | 2.3B | |
-2.54% | 186B | |
-1.85% | 107B | |
-4.26% | 67.44B | |
+1.39% | 50.03B | |
+16.82% | 47.81B | |
+4.79% | 41.03B | |
+3.49% | 26.85B | |
+0.65% | 25.82B | |
+0.01% | 25.01B |
- Stock Market
- Equities
- IART Stock
- News Integra LifeSciences Holdings Corporation
- Tranche Update on Integra LifeSciences Holdings Corporation's Equity Buyback Plan announced on December 10, 2020.